Janet S Hildebrand1, Susan M Gapstur2, Mia M Gaudet2, Peter T Campbell2, Alpa V Patel2. 1. Epidemiology Research Program, American Cancer Society, 250 Williams Street, NW, Atlanta, GA, 30303, USA. janet.hildebrand@cancer.org. 2. Epidemiology Research Program, American Cancer Society, 250 Williams Street, NW, Atlanta, GA, 30303, USA.
Abstract
PURPOSE: Physical activity is hypothesized to lower the risk of ovarian cancer, but current evidence for an association is limited and inconclusive. The purpose of this study was to examine moderate-to-vigorous physical activity, walking, and leisure-time sitting in relation to incident ovarian cancer, overall and by histologic subtype. METHODS: Moderate-vigorous recreational physical activity (MET-hours/week), recreational walking, and leisure-time sitting were examined in relation to epithelial ovarian cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort, a US cohort followed for cancer incidence from 1992 to 2011. Exposure information was collected via self-administered questionnaires. Cox proportional hazards regression was used to estimate multivariable-adjusted relative risks (RRs) and 95% confidence intervals (CIs) of total, serous, and nonserous ovarian cancer according to MET-hours/week, hours/week of walking, and hours/day of sitting. RESULTS: Among 63,972 postmenopausal women, 651 cases of ovarian cancer were identified during follow-up. Neither MET-hours/week nor walking was associated with risk. However, ≥6 h/day of sitting, compared to <3, was associated with higher risk of ovarian cancer (RR 1.44, 95% CI 1.12-1.85), particularly for serous cancer (RR 1.52, 95% CI 1.06-2.16), although statistical heterogeneity by histology was not detected (p = 0.36). CONCLUSIONS: Results from this study do not support an association between physical activity and ovarian cancer, whereas prolonged sitting may be associated with higher risk. Additional large studies are needed to further assess possible etiologic differences by histologic subtype.
PURPOSE: Physical activity is hypothesized to lower the risk of ovarian cancer, but current evidence for an association is limited and inconclusive. The purpose of this study was to examine moderate-to-vigorous physical activity, walking, and leisure-time sitting in relation to incident ovarian cancer, overall and by histologic subtype. METHODS: Moderate-vigorous recreational physical activity (MET-hours/week), recreational walking, and leisure-time sitting were examined in relation to epithelial ovarian cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort, a US cohort followed for cancer incidence from 1992 to 2011. Exposure information was collected via self-administered questionnaires. Cox proportional hazards regression was used to estimate multivariable-adjusted relative risks (RRs) and 95% confidence intervals (CIs) of total, serous, and nonserous ovarian cancer according to MET-hours/week, hours/week of walking, and hours/day of sitting. RESULTS: Among 63,972 postmenopausal women, 651 cases of ovarian cancer were identified during follow-up. Neither MET-hours/week nor walking was associated with risk. However, ≥6 h/day of sitting, compared to <3, was associated with higher risk of ovarian cancer (RR 1.44, 95% CI 1.12-1.85), particularly for serous cancer (RR 1.52, 95% CI 1.06-2.16), although statistical heterogeneity by histology was not detected (p = 0.36). CONCLUSIONS: Results from this study do not support an association between physical activity and ovarian cancer, whereas prolonged sitting may be associated with higher risk. Additional large studies are needed to further assess possible etiologic differences by histologic subtype.
Authors: Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Rikki Cannioto; John Lewis Etter; Lauren Beryl Guterman; Janine M Joseph; Nicholas R Gulati; Kristina L Schmitt; Michael J LaMonte; Ryan Nagy; Albina Minlikeeva; James Brian Szender; Kirsten B Moysich Journal: Cancer Epidemiol Date: 2017-05-18 Impact factor: 2.984
Authors: Anne McTiernan; Christine M Friedenreich; Peter T Katzmarzyk; Kenneth E Powell; Richard Macko; David Buchner; Linda S Pescatello; Bonny Bloodgood; Bethany Tennant; Alison Vaux-Bjerke; Stephanie M George; Richard P Troiano; Katrina L Piercy Journal: Med Sci Sports Exerc Date: 2019-06 Impact factor: 5.411
Authors: Andrea L Buras; Tianyi Wang; Junmin Whiting; Mary K Townsend; Brooke L Fridley; Shelley S Tworoger Journal: Am J Epidemiol Date: 2022-05-20 Impact factor: 5.363
Authors: Rikki Cannioto; Michael J LaMonte; Harvey A Risch; Chi-Chen Hong; Lara E Sucheston-Campbell; Kevin H Eng; J Brian Szender; Jenny Chang-Claude; Barbara Schmalfeldt; Ruediger Klapdor; Emily Gower; Albina N Minlikeeva; Gary R Zirpoli; Elisa V Bandera; Andrew Berchuck; Daniel Cramer; Jennifer A Doherty; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Marc T Goodman; Estrid Hogdall; Satoyo Hosono; Allan Jensen; Susan Jordan; Susanne K Kjaer; Keitaro Matsuo; Roberta B Ness; Catherine M Olsen; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Mary Anne Rossing; Elizabeth A Szamreta; Pamela J Thompson; Chiu-Chen Tseng; Robert A Vierkant; Penelope M Webb; Nicolas Wentzensen; Kristine G Wicklund; Stacey J Winham; Anna H Wu; Francesmary Modugno; Joellen M Schildkraut; Kathryn L Terry; Linda E Kelemen; Kirsten B Moysich Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-06 Impact factor: 4.254
Authors: Andrea L Buras; Cassandra A Hathaway; Tianyi Wang; Mary K Townsend; Shelley S Tworoger Journal: Cancer Med Date: 2021-03-11 Impact factor: 4.452
Authors: Rikki A Cannioto; Michael J LaMonte; Linda E Kelemen; Harvey A Risch; Kevin H Eng; Albina N Minlikeeva; Chi-Chen Hong; J Brian Szender; Lara Sucheston-Campbell; Janine M Joseph; Andrew Berchuck; Jenny Chang-Claude; Daniel W Cramer; Anna DeFazio; Brenda Diergaarde; Thilo Dörk; Jennifer A Doherty; Robert P Edwards; Brooke L Fridley; Grace Friel; Ellen L Goode; Marc T Goodman; Peter Hillemanns; Estrid Hogdall; Satoyo Hosono; Joseph L Kelley; Susanne K Kjaer; Rüdiger Klapdor; Keitaro Matsuo; Kunle Odunsi; Christina M Nagle; Catherine M Olsen; Lisa E Paddock; Celeste L Pearce; Malcolm C Pike; Mary A Rossing; Barbara Schmalfeldt; Brahm H Segal; Elizabeth A Szamreta; Pamela J Thompson; Chiu-Chen Tseng; Robert Vierkant; Joellen M Schildkraut; Nicolas Wentzensen; Kristine G Wicklund; Stacey J Winham; Anna H Wu; Francesmary Modugno; Roberta B Ness; Allan Jensen; Penelope M Webb; Kathryn Terry; Elisa V Bandera; Kirsten B Moysich Journal: Br J Cancer Date: 2016-06-14 Impact factor: 7.640
Authors: Tracy E Crane; Meghan B Skiba; Austin Miller; David O Garcia; Cynthia A Thomson Journal: JMIR Mhealth Uhealth Date: 2020-09-24 Impact factor: 4.773